Centre for Drug Research and Development
4
681K
3
0.29
1
0.25
- Areas of investment
Summary
Centre for Drug Research and Development appeared to be the Corporate Investor, which was created in 2007. The company was established in North America in Canada. The main office of represented Corporate Investor is situated in the Vancouver.
The common things for fund are deals in the range of 100 thousands - 1 million dollars. The high activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.
For fund there is a match between the location of its establishment and the land of its numerous investments - Canada. Among the most successful fund investment fields, there are Biotechnology, Diabetes. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Zucara Therapeutics, Sitka Biopharma.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Centre for Drug Research and Development, startups are often financed by Quark Venture, GF Securities. The meaningful sponsors for the fund in investment in the same round are Toronto Innovation Acceleration Partners, National Research Council of Canada Industrial Research Assistance Program. In the next rounds fund is usually obtained by The Leona M. and Harry B. Helmsley Charitable Trust, Canadian Glycomics Network.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Rounds per year
- 0.29
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (4)
- Pharmaceutical (3)
- Diabetes (2)
- Bioinformatics (1)
- Health Care (1) Show 1 more
- Investments by region
-
- Canada (4)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.75
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Zucara Therapeutics | 03 Nov 2016 | Biotechnology, Pharmaceutical, Diabetes | Seed | 525K | Canada, Vancouver, British Columbia |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.